British American Tobacco p.l.c. (BATS) Earnings Call Transcript & Summary
February 27, 2020
Earnings Call Speaker Segments
Operator
operatorGood day, everyone, and welcome to BAT's 2019 Preliminary Results Presentation. <<operator_script>> Kindly be aware that this call is being recorded. At this point, I'll pass things over to Jack Bowles, our Chief Executive.
Jack Marie Henry Bowles
executiveMorning, everyone. I'm Jack Bowles, the Chief Executive, and here with me this morning to present the results for full year 2019 is Tadeu Marroco, our Group Finance Director. Before I begin the presentation, I'll assume that all of you have seen and read the disclaimer on Page 2 and Page 3. As always, at the end of the presentation, you'll have an opportunity to ask questions. Last March, we laid out 3 clear priorities for transforming our business. I'm pleased to report that over the last year we have made good progress. We delivered value growth from our combustible business, gaining share globally with enhanced profitability. We are driving a step change in New Categories by launching new products and entering new markets, providing potentially reduced risk products to close to 11 million consumers. Lastly, in September, we announced some important organizational changes, which are largely completed. We have removed a net of 2,300 roles and recruited an additional 350 managers across the organization, creating the capabilities and resources to continue investing in new categories. This marks a significant first step in the journey towards making BAT a stronger, simpler, faster organization better equipped for the future.
Jack Marie Henry Bowles
executiveThis marks only the start of what we're setting out to do. Our mission is plain: we want to help create a better tomorrow by cutting the health impact of what we do, giving people more options for products that are enjoyable and carry lower risk. Our 2019 results showed solid operational delivery on every one of our main financial and strategic goals. As this morning's announcement made clear, reported figures took a hit from several adjusting items, most of them noncash. So that you can see more clearly what drove that solid operational showing, for the rest of this presentation we'll concentrate on constant currency adjusted numbers, except where we say otherwise. I'm very pleased to report that we posted yet another year of earnings growth in the high single digits. Revenue and profit each landed at the top of the range we guided to, and both group value share and group volume share rose. Operating margin went up even as we made substantial investment in New Categories. That robust revenue growth in New Categories came through despite the slowdown in the U.S. vapor category. It shows how strong our long-term multi-category strategy is. Our sharp emphasis on generating cash has helped us deliver on our priority of bringing leverage down -- that is, reducing leverage.
Jack Marie Henry Bowles
executiveWe’ve declared a 3.6% dividend increase, consistent with our 65% payout ratio and with our pledge to provide shareholder returns and grow the dividend in sterling terms. That means every commitment we laid out last year has now been met. Our approach to sustainability has been a key pillar of value creation in recent years. The health effects that are known to result from the cigarettes we sell remain the biggest challenge we face. Still, thanks to the investments we are making to grow our New Category business, we now have close to 11 million people using noncombustible products across 45 countries, including a leading 3.5 million consumers in the EU alone, and that number continues to grow. In our agricultural supply chain, we aim to deliver a positive social impact wherever we operate. We strive for excellence in managing our environmental footprint and have made some good progress. Since 2010, we have cut overall carbon emission by 24%, water withdrawal by 34% and waste to landfill by 60%. Finally, we strive to operate to a high standard of corporate governance. The broad range of external recognitions we have achieved over the years is a testament to our progress to date. BAT received the Organizational Impact Award in the SEAL 2019 Business Sustainability Awards, which puts us in the world's top 50 sustainable companies.
Jack Marie Henry Bowles
executive2019 is also the 18th straight year in which BAT has appeared in the Dow Jones Sustainability Index. And during 2019, we were the sole business in our sector to be listed on the World Index. To sum up, a great deal of progress has been achieved. That said, we recognize there is still more work ahead, and I'm looking forward to sharing further details with you at our Capital Market Day in March. We are executing against our 3 priorities, and today's results show the solid strides we've taken toward building a better tomorrow. Clearly, these results are helped by a very strong combustible performance, ongoing expansion in our new category products, and an organization that is already faster, more efficient and simpler. Beginning with value growth in our combustible business: revenue rose strongly, powered by value share gains, strong brands, good pricing and an improved geographical mix. Cigarette and THP volume fell 4.4%, which reflects the impact of the previously announced one-off stock reduction in Russia as well as lower industry volumes across a number of low market values, Egypt and Venezuela among them. Strip out those effects, and BAT group volume declined around 3%, consistent with global industry volume.
Jack Marie Henry Bowles
executiveAs we look toward 2020, we anticipate a decline of roughly 4% in worldwide industry volume, and that figure reflects significant excise-related drops in industry volume across Indonesia and Turkey. Within combustibles, our strategic brand portfolio keeps delivering strongly, with revenue up 5.6% for 2019. Overall combustible volume share and value share each rose 20 basis points. The strategic brands portfolio drove this through a volume share improvement of 70 basis points — helped by migration in Brazil — along with value share gains of 40 basis points. That makes it the eighth year in a row of group volume share growth, which speaks to a solid record of superior consumer insights and innovation. Our U.S. Strategic Brands keep reinforcing their position, with gains across every key value metric. We picked up share at the corporate level, in premium, and among adult smokers between 21 and 30 years old. Our leading ASU30 share now stands at 44%, which is ahead of our corporate share of 35%, showing the business has a strong outlook. Growth in New Category revenue came from a multi-category, multi-market approach. We posted more than 20% growth globally in every category and achieved double-digit growth in all geographic regions. It's worth noting that New Categories revenue growth, excluding U.S.
Jack Marie Henry Bowles
executiveVapor rose 39%, which aligns with the guidance we provided at the half year, prior to the contraction of the U.S. vapor market. Within vapor, we reinforced our worldwide standing and achieved constant currency revenue growth of 23% in spite of market turbulence. In Q4 2019, the category returned to sequential growth across key markets. We applaud the FDA's recent steps to bring clarity to U.S. vapor market regulation and back regulation aimed at delivering quality products for adult consumption. We are well positioned going into the May PMTA deadline and anticipate its enforcement. We estimate that GBP 1.5 billion of revenue could become contestable in the U.S. after that deadline. Our position is very strong, and we expect the benefit to materialize in 2021. Moving now to THP. This category expanded more slowly than in prior years, with Japan and South Korea together still accounting for over 60% of the total market. Better consumer satisfaction in this category will prove key to its future success, given the satisfaction gap versus cigarettes. Nonetheless, we keep seeing good opportunities for THP in particular markets, chiefly where cigarettes have low strength delivery levels and where fewer tobacco and nicotine other alternatives exist.
Jack Marie Henry Bowles
executiveSo because of that, our top priority is lifting how satisfied people are with our products, and putting our investment first in particular markets where we've spotted the biggest chances for category growth. Modern Oral is a small yet exciting new category, expanding quickly wherever it's available, and 70% of global volume sits outside of the U.S. We're a global leader -- a global category leader holding a volume share of 47%, backed by strong marketing and supply chain capabilities. So we're committed to delivering a better tomorrow, and the opportunities in New Categories excite us. The regulatory picture keeps shifting, as the recent moves in Russia and Mexico and the FDA's intervention on vapor show. With short-term visibility a challenge, staying agile and responsive matters. Annual growth rates are hard to predict. Still, we're clear about our ambition to hit GBP 5 billion in revenue for New Categories in '23/'24. We have to keep the investment flexibility to allocate resources as needed. That leaves us in a position of strength to put money into the business or to adapt to developments while still delivering on our financial targets. We're committed to delivering 3% to 5% revenue growth along with continued margin expansion, and the benefits of Quantum give us both the capabilities and the efficiencies to support additional investment as required.
Jack Marie Henry Bowles
executiveOur commitment is to achieve adjusted EPS growth in the high single digits and to keep generating robust cash, which will support additional deleveraging and rising dividends. As we look toward 2020: although vapor markets are recovering sequentially, they have not yet gotten back to where they stood before the U.S. vapor slowdown. We can't forecast how long the coronavirus will last or how far it will spread, but we have already observed some effect on our duty-free business and the earliest indications of New Category supply disruption at the retailer level. Since these factors are unpredictable, first half New Category revenue growth will be difficult, given the likelihood of growing out of stock and delayed new product launches. Even so, we do not anticipate this to affect our capacity to meet our financial guidance. To sum up, we are performing well and delivering on our 3 priority areas. The opportunities in New Categories remain exciting. As we consolidate our New Category brands, we are committed to investing further than building the capabilities required. Consumer and market insights clearly demonstrate that our multi-category strategy is key to deliver long-term sustainable growth. This is central to our ambition to create a better tomorrow. I will now hand over to Tadeu, who will take you through 2019 in a bit more details.
Tadeu Marroco
executiveThank you, Jack. As we noted at the start of the presentation, during 2019 we once again met our financial commitments, and we achieved that while persisting with substantial extra investment in our future. A 50 basis point margin improvement was achieved together with an incremental GBP 500 million market investment in new categories. Strong free cash flow after dividends of GBP 1.9 billion came in above our guidance of GBP 1.5 billion. That highlights our capacity to grow the dividend sustainably, keep a 65% dividend payout ratio and at the same time cut our leverage by 0.4x at constant rates. Total revenue rose 5.6%, ahead of our guidance range of 3.5%, powered by the strong performance in combustibles and our growth in New Categories. Profit growth of 6.6% was also at the top end of our guidance range, with revenue growth and operating margin growth driven by strong performance across our markets. Performance was good across the regions. In APME, total revenue rose by more than 5%, powered by good price/mix and growth in New Categories. Value share rose by 30 basis points, led by gains in Japan. Profit from operations rose nearly 8%, with strong growth in Japan and the Middle East alongside additional investments in New Categories.
Tadeu Marroco
executiveWithin AMSSA, revenue rose by more than 9%, and value share climbed 20 basis points. South Africa stood out in particular, coming back to growth in volume, revenue and profit, alongside a decline in illicit trade. Profit from operations was 10% higher, powered by gains in Brazil, Canada, Chile, Nigeria and Mexico. Over in ENA, revenue was up 5%, thanks to solid pricing throughout the region. Cigarette value share came in slightly above last year, with Romania, Ukraine and Russia performing well. Profit from operations increased 3%, reflecting good results in Germany, Turkey, Romania and Poland, though these were offset by the stock reduction in Russia and extra investments in New Categories. Now to our biggest region, the U.S. Results there were strong, with revenue and profit from operations rising by more than 4% and 6%, respectively. The combustible business drove this, posting revenue growth of nearly 4% on the back of good pricing and lower discounting, which data analytics helped support. That more than made up for volume, which fell 6% on a shipment-to-wholesale basis. The industry itself was down 5.3%. As we look toward 2020, we anticipate industry volumes declining by roughly 5%, a modest improvement over 2019. That reflects the gains from a reduction plus the boost from vapor growth, which are largely offset by legislation that raises the minimum age for buying any tobacco product to 21.
Tadeu Marroco
executiveOperating profit increased by over 6%, thanks to solid revenue gains and cost reductions, which offset higher market investment in New Categories. After the Reynolds acquisition and the license synergies—primarily procurement, R&D and overheads—more than $400 million has been delivered, a year ahead of plan. Our operating margin rose 100 basis points, reaching 48.5%. In U.S. vapor, Vuse increased its value share and we took the #2 brand spot in that market, significantly beating the industry during the second half. Over the second half, Vuse's value share climbed more than 8 percentage points, hitting 21.2%, fueled by Alto's success, with its value share rising over 12 percentage points to 15.4%. Closed systems account for 6% of U.S. vapor markets at present. Beyond the U.S., we reinforced our vapor leadership. In ENA, vapor revenue rose 30%, powered by Vype, whose revenue grew 110%. We are expanding volume and value share across every established vapor market, among them the U.K., France and Germany. In newer vapor markets, Vype has become a market leader in Hungary, the #1 brand in Belgium, and shows strong early momentum in Spain. Lastly, we closed the Twisp acquisition in South Africa during Q4.
Tadeu Marroco
executiveThat reinforces our network spanning retail outlets and e-commerce platforms and gives us market leadership in vapor within South Africa. In THP, the fourth quarter brought the launch of our 3 new glo variants: glo Pro, the first product to employ induction heating technology; glo Nano, a design upgrade replacing glo Mini; and glo Sens, a hybrid product. glo Pro has demonstrated solid early traction with consumers, fueled by the advantages of its induction technology, with consumers pointing to the more satisfying product experience, the boost function and faster ramp-up as key benefits. As for glo Sens, following an encouraging launch, consumer uptake has shown less traction than we anticipated. We are enhancing our in-market execution, widening device penetration, lifting trial to conversion rates and putting plans in place to drive better consumer uptake. Overall, THP revenue rose 23% with consumables volume increasing 32%. In Japan, we hit a record BAT volume share of total nicotine of 19.2% in January. THP category growth in Japan has dropped from 67% in 2018 to 6.5% in 2019 owing to market saturation. Furthermore, competitive intensity has risen with the proliferation of new product launches. These market dynamics look set to persist as we move into 2020, with THP category growth in Japan expected to moderate further.
Tadeu Marroco
executiveEven so, glo's most recent weekly share of total nicotine has climbed to 5.2%. In the rest of ENA, THP remains a small category, concentrated in only 3 markets that make up 57%. From a low base, our progress is steady. glo has shown especially strong momentum in Eastern Europe, in markets that generally have lower tar. In the capital cities of Russia, Kazakhstan and Ukraine, category share now stands at 10%, 32% and 10%, respectively. Turning to Modern Oral. In ENA, which represents 2/3 of the worldwide category, our Modern Oral revenue grew by more than 240%. In Sweden, Lyft leads modern oral brands with a 58% category share. And in Norway, BAT is the fastest-growing modern oral company, with a category share of 71%. Just 6 months after launch, we are pleased with how Velo is performing in the U.S., where it has captured a 10% volume share of the modern oral category and 29% of the growing under 6-milligram category. During 2019, the under 6-milligram segment accounted for 34% of the category, an increase of 6 percentage points. Since we concentrated our initial launch rollout in the eastern states in order to test and learn, we are pleased to see notably higher share performance there.
Tadeu Marroco
executiveWe're constrained by manufacturing capacity of 2 billion pouches. The national support plans haven't been fully activated yet, and we'll redeploy what we learned from the initial launching states. In Atlanta, where all 3 categories are present, we're seeing strong development of modern oral and vapor, with very little traction for THP. Over the last 6 months, our U.S. business has grown share of total nicotine in Atlanta faster than it has nationally. Moving on to operating margin, which was up 50 basis points. The 300 basis points of incremental New Category investment went toward developing and launching new products, platforms and digital capabilities. That helped us drive robust New Category growth in 2019 and has also strengthened our platform to support growth in the years to come. This incremental investment was more than offset by the 390 basis points of margin support. That came from pricing and improved geographic mix, gross margin expansion, SKU rationalization. Looking into 2020 and beyond, the benefits of Quantum mean that we'll be able to keep investing for the future and deliver margin expansion. Our key highlights of the group's performance in 2019 included its strong cash generation, resulting in leverage of 0.5x at current rates and 0.4x at constant rates, in line with our guidance.
Tadeu Marroco
executiveFree cash flow, after dividends of GBP 1.8 billion at constant rates, came in driven by operating cash flow conversion of 97%, which is ahead of our medium-term target of 90% or more. At constant rates, adjusted net debt dropped GBP 0.8 billion, thanks to our strong cash flow. That held true even with GBP 0.4 billion of other cash and noncash items, mainly hedging, plus recognition of a higher lease liability when we adopted IFRS 16, which added GBP 0.6 billion to net debt. At current rates, adjusted net debt went down by another GBP 0.9 billion to GBP 41.7 billion from FX translation, stemming from sterling strengthening against the U.S. dollar. For 2020, gross CapEx should come in around GBP 650 million, in line with adjusted depreciation. We expect operating cash conversion above 90% and stay committed to a 65% dividend payout ratio, growing in sterling terms alongside continued leverage of the balance sheet. Leverage on the balance sheet remains a priority. Since current FX rates are a headwind, we expect to bring adjusted net debt to adjusted EBITDA down to roughly 3.2x at current rates by year-end and then under 3x by the end, 2021.
Tadeu Marroco
executiveWhen you look at it on a constant basis, adjusted diluted EPS rose 8.4%, which means we delivered on what we committed to for high single-figure earnings growth. At current rates, adjusted diluted EPS was higher by 9.1%. The rise in net finance cost at constant rate came mainly from short-term funding of working capital movements as well as interest on leases under IFRS 16. For 2020, we anticipate net finance costs will be stable at roughly GBP 1.5 billion. Associate income went up thanks to a good performance of -- from ITC, and the Indian tax reform gave it further help. The underlying tax rate came down to 26% in 2019 from 26.4% in 2018. My expectation is that the underlying tax rate for 2020 should fall further, to approximately 25.5%. Combined with stable net finance costs, that means in 2020 we expect a similar benefit to EPS growth from items below operating profit. We expect one more year of high single-figure constant currency earnings growth, with results, in particular New Category revenue growth, weighted toward the second half. Given our current foreign exchange rates, earnings would face a headwind of about 4% if FX rates stay unchanged for the remainder of the year. Thank you. I'll now hand back to Jack for his closing remarks.
Jack Marie Henry Bowles
executiveThanks a lot, Tadeu. In summary, the business is doing well. We're meeting our financial commitments and delivering high single-figure constant currency earnings growth for another year, while also making substantial extra investment for the future. Our focus will stay on our 3 core priorities as we work to create a better tomorrow. With the consumer at the center, we are transforming the company, building strong brands, and delivering value from our combustible business — which provides the resources to invest significantly behind a multi-category business. As we look ahead to 2020, we're confident of another good year of high single-figure earnings growth. Another dividend increase reflects our confidence in the future of BAT. Thank you — I'll now open it up for questions. Yes?
Gaurav Jain
analystGaurav Jain from Barclays here. I've got a few questions, and they all tie together. First, could you speak to how U.S. cigarette volumes have performed year-to-date? You said there's a supply constraint now affecting e-cigarettes in the U.S. So is that hitting you as well as your competitors? And if it continues, might that end up benefiting U.S. cigarette volumes?
Jack Marie Henry Bowles
executiveApologies—let’s pause at that point and pick up afterward, if that’s alright. Yes, I mean regarding the U.S. market. So naturally, I won’t go beyond what we said earlier, but I think we don’t see any material difference between Q4 and how the business performed at the start of the year. So I think the U.S. market is coming out nicely from the crisis related to e-cigarettes. Of course, the growth happening at the moment did not fully recover what happened in the second half of last year. But we see good potential for the U.S. market. On your second question about the supply disruption, first of all, we have to be cognizant of the fact that it’s a terrible thing happening related to that coronavirus, and there are lots of dead persons. And we’re doing all the support and giving all the support we can to our teams first, but also to all the partners we’re working with, all the manufacturers we’re working with. Most of the factories are now open, yet we see here and there some attention in terms of supply chain and some limited out of stocks in retailers in some geographies.
Jack Marie Henry Bowles
executiveYou just need to keep in mind that I won't be commenting on possible out-of-stocks among competitors. But, as I mentioned, we are seeing some in various locations. To begin with, we have a very solid business across the globe. China's share of our overall revenue base is extremely small. And most — nearly all — of our manufacturing footprint for cigarettes sits outside China's territory. And at present we don't see any inflection point other than duty-free, which, naturally, is affected by the drop in traveler numbers, but that is extremely marginal within our total business. So those were your first 2 questions. Did you have more?
Gaurav Jain
analystOkay, let's turn to Modern Oral in the U.S. Right now you hold a 10 percentage share after 6 months—or 7 months—of being on the market. And the larger competitor is going to come into that market later this year. So how would you gauge success there?
Jack Marie Henry Bowles
executiveYes. I think what matters a great deal to us is that we have a presence in 3 categories across the world, and we're gaining share in those 3 categories. That's where we start from. So we're not just delivering growth in those 3 categories but also very strong growth in the combustible business. I think that, specifically on oral tobacco, as we said, we're the worldwide leader when it comes to oral tobacco, and even in Scandinavia, which is, I would say, the place where all these products began, we're beating all competition when it comes to modern oral. In the U.S. specifically, we have very good performance with the Velo brand, and I said I'm very pleased with the results. We have no constraint when it comes to supply. And as Tadeu explained earlier, we took the opportunity to learn about that category, as we do all the time, and we now have a distribution of more than 70% but an active distribution of around 15%. If you take the position that we have, for instance, where all the different categories are present in Georgia and also in Atlanta, we have close to 40% share in oral tobacco. So I think that we have the potential and the runway to keep accelerating when it comes to New Categories.
Nico von Stackelberg
analystNico Von Stackelberg at Liberum here. Just a quick one about dividend growth. My understanding was that in a fairly poor year, the dividend would rise by roughly 4%. It came in slightly under that. So I was simply wondering whether you could walk through the reasoning behind it?
Tadeu Marroco
executiveJust as we've always done, delivering on what we promised—a 65% payout ratio—that is precisely a 65% payout. We are, of course, very careful with cash, as you can imagine, and we're working hard to bring down the company's leverage. We judge this to be good compensation in dividend terms, and we're holding to the policy we've established for ourselves.
Nico von Stackelberg
analystSo that's my second question, I suppose. I'd like to understand more about how products are used in the U.S. and about the PMTA.
Jack Marie Henry Bowles
executiveSorry, what was that?
Nico von Stackelberg
analystOn the PMTA side for product applications, could you walk us through your priorities when it comes to PMTA? Are there particular major categories you see yourselves not submitting for PMTA — tobacco heating products, THP, for instance? Will that be the lead PMTA product there? And more broadly, could you speak about modern oral PMTA?
Jack Marie Henry Bowles
executiveYeah. I think our top priority is on e-cigarette and oral tobacco. We've said it many times: we're going to do tobacco mint and the other flavors, and those are the ones we'll pick. We want to be sure we're strong in this environment. And when it comes to THP, we already have a product under review with the FDA. What matters most to us is the fact that from a market that was extremely segmented, or extremely atomized when it comes to the number of players and the number of SKUs and open system, you now have a market in the U.S. where 60% of the sales are done in closed system, which plays to our strength. And the second thing is we see that there's a contestable space that is going to happen as a consequence of the filtering of the FDA process of $1.5 billion, to which you will have most of the benefit that will come rather in '21 and most of it in '22. Why? Because it will take time for the FDA to process all the information that we'll receive. I remind you that we've already put some PMTA applications in the system in order to test the grounds more for the administrative side of it, and just these SKUs represent 150,000 documents and took more than 27 hours to download.
Jack Marie Henry Bowles
executiveThis is going to be a demanding undertaking, and we will back the FDA to the fullest extent we can, and we are already in touch with the FDA to ensure this proceeds as smoothly as it possibly can.
Nico von Stackelberg
analystAnd my last question concerns the U.S. vapor opportunity when it comes to profitability. I mean, I can see how this turns into a profitable segment after PMTA, but could you provide some kind of color from your end regarding how you view profitability in this category developing, say, over a 5-year view, please?
Tadeu Marroco
executiveWe have several levers we can pull to boost profitability in vapor. One involves product costs and the entire supply chain. Reviewing what opportunities exist to improve and cut cost and lift gross margins is a constant topic for us. The second is how we can strengthen our direct-to-consumer assets, and we're investing heavily in e-commerce and becoming more able to lower trade margins as a result. There's already a trend, as I explained, in the closed system, which benefits us. And certainly, PMTA will open up a contestable space of around $1.5 billion. And we believe we're very well positioned with the products we currently have, and the momentum is there. So I think this will all work together, because it will generate more scale and also translate into improved profitability.
Nico von Stackelberg
analystSo I suppose what I'm really asking is this: looking out 5 years, what ought I to be putting into my model, broadly? Could you perhaps give me some kind of range for that segment's profitability?
Jack Marie Henry Bowles
executiveWe're looking at GBP 5 billion in New Categories, and we need to proceed gradually. Things are changing fast on the regulatory side. When you look at how the different categories are taxed — the 3 categories, THP — you can see they're moving increasingly toward full taxation on tobacco. That's already the case in North Asia, and it's already the case in the U.S. On e-cigarettes, there was a fragmentation of the market that was very important. And now we're seeing concentration in closed system. There's more product, so watch it — that will create a concentration. And as Tadeu said, having bigger brands, more economies of scale and distribution, that will cost you less, because now that we have age verification competitors that has applied, then suddenly, I'm in agreement with our marketing colleagues to go for e-cigarettes into e-commerce. But we have to make sure that we understand — and it's not the time to give guidance related to these things, it's the time for us to take leadership in these different categories and to make sure that we have the right products on the right consumer. What matters most to me is that, because we have been multi-category since many years now, we have reinforced our capabilities.
Jack Marie Henry Bowles
executiveLike I mentioned, we've brought on 350 managers across all those New Categories areas — everything from product development and design through to insights. We're the only 1 with 4 categories in site available to us, and we've run pilots, market tests, and launches that came off successfully. Off the top of my head, ePen 3 and the European counterpart of the Alto is product of the year. That tells you the consumer reception is extremely good. Building on that foundation, we're gaining share in these 3 categories, and we'll keep doing that.
Nico von Stackelberg
analystAnd here's my last question, if you don't mind. When I see how wide the difference is between adjusted and reported profits, clearly many of those one-offs really are one-off by nature, and I appreciate that you've put numbers on them, which is quite helpful, so thank you for that. But I suppose what I'm asking is, for the coming year and perhaps for the next couple of years, could you give us any sort of color on what that gap might look like? Or what restructuring charge you might anticipate? Broadly, if you could lay out your thinking on that going forward.
Tadeu Marroco
executiveYeah. I think looking at restructuring matters here. Since 2018 we've been going up, largely because of the Quantum project on the restructuring side. That piece is simply part of restructuring. Beyond that, as you mentioned, the bulk is a noncash item, and predicting it is hard. And one of the largest single items involved the charge tied to the Québec case, which we already disclosed at the half year. On cash flow, 2019 showed a modest decrease in adjusting items versus the prior year. And even though 2020 brings larger items to cover — Quantum itself plus the tax case in Russia — we're already at work, and given the other actions we're taking, we don't expect cash to follow a larger trend next year. After that, if we must keep going with Quantum, that's a restructuring process. Still, estimating the total adjusting item is difficult, since some elements there are, as you said, very one-off. Yes, San.
Sanath Sudarsan
analystSanath from Morgan Stanley here. I've got 3 questions, mostly about the U.S. market. First, you gave your outlook on U.S. cigarette volumes for 2020 — where you see them landing, around 5%. Could you walk us through how you're thinking about the drag, or the smaller drag, coming from vaping, plus what Tobacco 21 does to your figures. And maybe just...
Jack Marie Henry Bowles
executiveMay I take that one first? Then we’ll move on to the other question. So, on 2021 — that’s a really good question. Thanks so much for asking it. At this point, you already have 15 states in the U.S. that are above 21 years old, and what we observed was that the impact was very minimal. But for a responsible company like ours, it’s a very good regulation coming forward. Then the second thing is that you have to remember that in the U.S., we have a share above 21 years old of 44% annual <<inaudible>>, so we are better positioned than our current total market share in the U.S. So that was for your first question. Then your second question?
Sanath Sudarsan
analystAnd I guess, over a longer horizon as well, you've always mentioned that historically you bring in new nicotine users too. How do you expect that to develop in the U.S.? Or did you observe it in 2020 or 2019? And looking ahead, after '21 -- Tobacco 21 following PMTA, what's your view on that consumer acquisition going forward?
Jack Marie Henry Bowles
executiveYeah. I mean, I don’t want to get too deep into specifics since that touches on forward-looking matters, but what happened in 2019 with the e-cigarette crisis was that you didn’t really see e-cigarette consumers flooding back into cigarettes; instead, combustible users became less inclined to move into e-cigarettes because they felt uncertainty about the product. I’d say the regulatory framework the FDA has introduced is a sound one. It represents a first step — a very substantial first step — in the right direction, and additional steps may follow.
Sanath Sudarsan
analystSo a competitor of yours made a remark at CAGNY that, by the close of this decade, they'll likely have equal-sized revenues in NGP and combustible in the U.S. Do you have a strong view on that? Or how do you see that market evolving there?
Jack Marie Henry Bowles
executiveAt the start of my presentation, I believe I was very clear for the first time about our purpose, and I'd like to bring you back to that point. The key thing is this: we have strong confidence in how good our tobacco business is, and we equally believe you must simultaneously have a powerful position in New Categories. There are 3 categories that matter to us, since our view is that one size does not fit all. We genuinely think consumers hold certain aspirations when it comes to risk-reduced products, and that you need multiple approaches depending on geography, on culture, on the excise environment, and on the regulatory environment. Naturally, coping with that demands a great deal of energy and a great deal of resources. Still, I think it hands us an advantage over every competitor throughout the industry when it comes to succeeding in the future. That is why I repeat: notwithstanding the crisis and the scale measures that took place last year and this year, we will reach GBP 5 billion going forward as an ambition.
Sanath Sudarsan
analystThen I’ll cheekily ask just one final question. Regarding the leverage you mentioned, you’ll be under 3 turns by 2021. Internally, is there a target for where you’d like to land? Or what’s the optimum rate you’d prefer to have?
Jack Marie Henry Bowles
executiveNo, that's a really good question. I won't provide a target on that. What I'm saying is that one of the main reasons we cut guidance this year — the guidance numbers, where we say 3% to 5% on revenue, high single-digit on EPS, the 65% on dividend, and the deleveraging — is that I want a bit more room to be able to seize the opportunities in the market while still delivering on the company's financial metrics, and we'll keep doing that. In the first year, last year, we faced a more difficult situation. We gave more guidance. I think it's more reasonable now to be in a position where we have a little more room in order to make the right calls for the business and to invest. I'll just remind you that in 2019, we are delivering the financial results, and at the same time, we invested GBP 500 million more in marketing investments — GBP 500 million more. And I will keep investing in the New Categories at the right pace to make sure that our multi-category approach is the right one and that it is showing the right approach from the consumers.
Jack Marie Henry Bowles
executiveThanks. Adam — yes? My apologies, Adam.
Adam Spielman
analystCan I — as I always do — ask you roughly three questions?
Jack Marie Henry Bowles
executiveLet's take these one at a time, since your questions always cut right to the point, and I want to be sure I get each one right.
Adam Spielman
analystFirst question: could you discuss Japan — where you've achieved a lot of success within the little cigar segment?
Jack Marie Henry Bowles
executiveApologies — could you repeat that?
Adam Spielman
analystRegarding little cigars. This new...
Jack Marie Henry Bowles
executiveOh, yes, yes, yes.
Adam Spielman
analystCould you speak to how you’re not seeing — well, more importantly, how you expect that to play out going forward? That’s the first question.
Jack Marie Henry Bowles
executiveAll right, let's begin with that one. Thanks, Adam. I believe there was a historical situation in Japan — namely, reduced taxation on certain cigarette products, standard cigarette products. That has been shut down, and the government in Japan will phase it out gradually. The second point is that an opportunity existed around what I'd call mini cigars, which function somewhat like cigarettes, and we seized it because, unlike other players, we view the combustible business as extremely important. That's why, when we discuss our results in Japan, we cite a 19.1 share in terms of the total nicotine offer on the market. That category, just like the lower taxation that historically existed in Japan, will close and it turns around. That provides us — and has provided us — with the ability to keep growing in that category. I think it was a highly useful step toward achieving a better value share and a better market share in Japan. Did that address your question, Adam?
Adam Spielman
analystI believe that's right, and it's quite clear. Moving on, the next question — likely the most significant one — concerns trade. Actually, let me begin with something else: menthol regulation at the state level...
Jack Marie Henry Bowles
executiveWhen you mention menthol rules at the state level, is it the U.S. you mean?
Adam Spielman
analystRight, so on the U.S. side, we're seeing a growing number of states that are at least putting menthol bans on the table. How worried should we be about that?
Jack Marie Henry Bowles
executiveI think there are 2 things here. First, it's a really good question. One is that the FDA, after all these years, still permits menthol in cigarettes and continues to permit menthol in e-cigarettes as well. And that's very recent, so there's no new science behind it. At the state or city level, some choose to ban menthol. Okay, so what happens is the U.S. has 50 states, and the borders are what they are in the U.S. So you see what I'd call a possible acceleration of cross-border activity. And I don't believe this will be something that's very sustainable going forward. But I understand why cities or states take that view. Are we in favor of it? The answer is no, because we believe in consumer choice, and no material scientific evidence has stated there's a problem tied to menthol. Did that answer your question, Adam?
Adam Spielman
analystYeah, I believe that's right. Now, on your third question, which is broader: you've mentioned previously that you want to build a stronger process for innovation and, possibly, sharper commercial execution on the next-generation products. So could you just explain how the way you develop new products is getting better? Has anything changed over the last 12 months? And how do you see that changing...
Jack Marie Henry Bowles
executiveAbsolutely. Without a doubt. What we've done, I mean, is we've invested heavily when it comes to insight. Another area where we've moved quite rapidly is anything tied to big data. Social listening also plays a very significant role. Beyond that, on the definition side — that concerns the consumer. And beyond that — keep in mind we're the only company holding data, information, and insight across 4 categories. Right? Beyond that as well, something very important to us is that the 4 Ds of R&D used to be split across the company, and today they all sit together. So there's a single body, the new category group, examining all of this, with strong backing from IDT — that is, digital and technology. What I believe this provides is the ability to operate far better and to grasp consumer needs far better. One of the things that's perhaps the most significant is the satisfaction consumers derive from these products. And you're aware that in THP, for example, there's 25% segment share of total nicotine in Japan, and that's the only country worldwide.
Jack Marie Henry Bowles
executiveSo in Korea, you know, it hit a peak and has now come down to 8%, even with the players present there, including the strong local company. In Europe, we know traction exists in only a very small number of countries. And we know that as you move further into the scale of tar and nic — take Canada, for example: even though THP arrived there 3 years ahead of e-cigarette, e-cigarette today is considerably larger than THP. We know that in the U.S. — but that's only the — in this infancy stage, we'll see how it develops. And I'm not downplaying the possibility that THP can grow in the U.S., but the environment doesn't look very favorable, I would say, in the sense that you already have 2 other categories that are extremely well established. And when we see that 2 other categories are well established, it becomes very difficult for the third category to grow. So I think what we've done in terms of our R&D and our understanding of the consumer has been stepped up massively, and we invested much more money over the course of 2019 to make sure we deliver on that.
Adam Spielman
analystAnd just to build on that, should we anticipate the same vapor will see significant new products? And how — when will we start seeing some results from a better process?
Jack Marie Henry Bowles
executiveYeah, I think — I don’t want to go — Adam, that’s a really good question. I’d rather not get into product definition, because that would reveal too much. But yes, the reality is that you now have the segment, and we are a worldwide leader. If you look at the segment itself, the number or the percentage for closed system is there, rising and very strong. That carries a very, very important consequence: the regulatory framework and product stewardship. You have a device that goes with the liquid that goes with the system. This is where things are headed going forward. After that, you need to make sure you keep developing these products. And the products we currently have on the market will evolve over the next 2, 3, 4 years, because there are many cost opportunities and opportunities to improve satisfaction going forward. Other questions? From what Mike is telling me from the back, that would potentially be the last question or the last 2 questions.
Charles de Zuniga
analystChas Manso here from SocGen. I've got a couple or a few questions, if that's alright. I'll go one at a time. To start, here's a quick one.
Jack Marie Henry Bowles
executiveSince I'm French, you'll need to take it slowly with me.
Charles de Zuniga
analystHas there been any movement in the talks up in Canada? And can you break out what Canada's profitability was in...
Jack Marie Henry Bowles
executiveCCAA, CCAA?
Tadeu Marroco
executiveCorrect.
Jack Marie Henry Bowles
executiveCorrect.
Charles de Zuniga
analystHas any progress been made when it comes to forming a resolution?
Tadeu Marroco
executiveYes, so the industry is currently negotiating via a mediator that was set up with the plaintiffs — not only in Ontario but across every province. What we've heard most recently is that a stay on all proceedings was extended through September. And we're confident we'll be able to reach a negotiated outcome that reflects a going-concern perspective for all parties going forward. But I can't elaborate further, since the process is quite confidential at this point.
Charles de Zuniga
analystYou brought up the extension running through September. Is that meant to cover just the start of the process, or is there some timeline for when a possible resolution could come?
Tadeu Marroco
executiveNo, it’s simply that they have a hold in place while they try to reach some kind of agreement. Honestly, though, I don’t anticipate anything occurring near term. I mean, by the end of the year, perhaps in a couple of years.
Charles de Zuniga
analystAll right. Next, coming back to aged tobacco — it's clear your attention is mainly on Eastern Europe. So let me make sure I have this right: in 2020, your tobacco investment beyond Japan will be sharply concentrated on Russia, Kazakhstan, and Ukraine.
Jack Marie Henry Bowles
executiveSure — so we plan to grow our presence across all 3 categories, and we’ll make certain we’re highly successful in the places we enter. I think we’ll take it one step at a time. And, as I mentioned earlier in response to Adam’s question, one thing that matters enormously — and I appreciate that question — is that during 2018 and 2019 we built the capabilities and the resources, we put those resources in place, so that we can keep growing. Even with THP and oral, you’ll recall I said last year that we’re using our existing tobacco machines to produce our THP products, because I don’t want to wind up with CapEx exposure that is far too high relative to the regulatory framework. So I think Tadeu stated very clearly that CapEx will be in line with depreciation. In 2020, that’s the first year in many years we’re able to do so, and that’s very good news on that front. So our geographic footprint will keep expanding, but we’ll discuss that further at the Investor Day.
Charles de Zuniga
analystAnd finally, regarding the regulatory side and that sort of thing. Is there any indication that groups such as the WHO are shifting considerably more toward a harm reduction perspective? Or are we still stuck in a kind of differential world where, in particular, transnational organizations continue to believe in quit or die?
Jack Marie Henry Bowles
executiveYes. I think the key thing here — and it's a really good question — is that you need to put the consumer first. And consumers are purchasing the items that we sell. We've got excellent products you want to ship on these products, and we'll keep doing that. Second, we take a highly responsible marketing approach across everything we do. Why? Because that's about the sustainability of the group going forward. And the third thing, also very important, is that we'll proceed step-by-step in developing these products, and we engage with regulators as required — whether the FDA or other bodies across the geographies where we operate — so that the right scientific base is presented to them and the right benefit of these categories is put to them. Okay. Last one? No. So thank you very much. I mean, I have to say, as you know, this is my first year as CEO, and before that I was COO, so I know this company very well. I know the muscle that this company has. We've done a lot of restructuring in our business to become faster, simpler and more agile.
Jack Marie Henry Bowles
executiveWe're executing on that, and we're doing it over a short timeframe. Why? Because my aim is to transform this company quickly. During 2018 and 2019 we built the foundations for a strong base in our tobacco business — a very strong base there, with substantial revenue growth and gains in value share — and from that base we are drawing the resources to grow our New Categories. In 2019 we put an additional GBP 500 million into the New Categories. We increased share across the 3 categories. We came in within the guidance, and we will keep performing in these New Categories and keep growing share; naturally, there will be skirmishes everywhere, since some country always decides its regulatory framework must change, and some country always decides that a little more taxation is needed in these various markets. Overall, what we want to build is a better tomorrow for society, for the stakeholders we have, and that includes the shareholders. Over the last 2 years we have shown that, despite the waves and despite the negative environment that has existed, we were able in 2019 to deliver revenue growth of 5.6%, to deliver the dividend, and to make sure we keep delivering deleveraging for the company — and we will carry on doing so.
Jack Marie Henry Bowles
executiveOffering less guidance is the right approach, since that gives me flexibility to move forward, though we will provide guidance on the most important elements. After that, I will navigate the different opportunities, because the whole aim is to gain opportunities and flexibility in the organization and in our resource allocation. As we said, we will continue to deliver in 2020 — in terms of 3% to 5%, and in terms of high single-digit related to EPS. Thank you very much.
Operator
operatorThat brings us to the end of today's conference call. Thanks to everyone for joining. You can go ahead and disconnect your lines now.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete British American Tobacco p.l.c. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to British American Tobacco p.l.c. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in British American Tobacco p.l.c. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.